Press "esc" to clear
Go to Advanced Search

Showing results

110 of 622

Article ID: 697704

How Tendon Transfer Surgery Restored Hand and Arm Functions to Spinal Cord Injury Patient

Loyola University Health System

After suffering a severe cervical spinal cord injury from a bad fall at work, Scott McConnell had little function remaining in his hands and arms. Loyola Medicine orthopaedic surgeon Michael Bednar, MD, was able to restore key functions with a series of operations called tendon transfers.

Released:
20-Jul-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697671

American College of Rheumatology Responds to the CY 2019 Physician Fee Schedule and Quality Payment Program Proposed Rules

American College of Rheumatology (ACR)

The American College of Rheumatology expressed concerns that the proposed cuts to cognitive E/M services, along with the methodology changes to PE, will further restrict patient access to rheumatologists and other cognitive specialists at a time when the workforce is already shrinking.

Released:
19-Jul-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    19-Jul-2018 2:00 PM EDT

Article ID: 697490

Broken Bones Among Older People Increase Risk of Death for Up to 10 Years

Endocrine Society

Broken bones among older people increase their risk of death for up to 10 years, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Released:
17-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697621

Prolonged Opioid Use Before Knee or Hip Replacement Surgery Increases Risk of Poor Outcomes

Wolters Kluwer Health: Lippincott Williams and Wilkins

Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.

Released:
18-Jul-2018 3:30 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697517

NeuroPoint Alliance Welcomes Mayfield Brain & Spine to QOD

American Association of Neurological Surgeons (AANS)

Mayfield Brain & Spine joins over 100 existing QOD participating centers.

Released:
17-Jul-2018 9:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697158

Mary K. Crow, MD, and Jane E. Salmon, MD, Named Honorary Members of the European League Against Rheumatism

Hospital for Special Surgery

Mary K. Crow, MD, physician-in-chief and chief of Rheumatology, and Jane E. Salmon, MD, rheumatologist at Hospital for Special Surgery (HSS), have been named honorary members of the European League Against Rheumatism (EULAR) during the Annual European Congress of Rheumatology in Amsterdam.

Released:
12-Jul-2018 4:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697372

Novel Therapy Delays Muscle Atrophy in Lou Gehrig’s Disease Model

Case Western Reserve University

Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted during Lou Gehrig’s, the new study suggests supplementing it could be a novel therapeutic approach for the disease.

Released:
12-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Illustration.jpg
  • Embargo expired:
    12-Jul-2018 11:00 AM EDT

Article ID: 697253

Researchers Discover Gene That Controls Bone-to-Fat Ratio in Bone Marrow

University of California, Los Angeles (UCLA), Health Sciences

UCLA researchers have found that the PGC-1α gene, previously known to control human metabolism, also controls the equilibrium of bone and fat in bone marrow and also how an adult stem cell expresses its final cell type. The findings could lead to a better understanding of the disruption of bone-to-fat ratio in bone marrow and its health consequences, and point to the gene as a therapeutic target in the treatment of osteoporosis and skeletal aging.

Released:
10-Jul-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 697194

La genómica de precisión señala el camino hacia mutaciones relacionadas con envejecimiento acelerado

Mayo Clinic

Los investigadores de Mayo Clinic aplican la genómica de precisión para buscar mutaciones genéticas, aún no descubiertas y hereditarias que aceleran el envejecimiento.

Released:
9-Jul-2018 5:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
D_1509_089_0111.jpg

Article ID: 697050

Graphene Foam Could One Day Ease Osteoarthritis Joint Pain and Prevent the Need for Joint Replacement

Boise State University

Previous studies have shown graphene foam’s compatibility with chondrogenic cell lines for cartilage tissue engineering; this is the first to focus on the viscoelastic behavior of the engineered tissue to test the functionality of the grown cartilage.

Released:
5-Jul-2018 3:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 622





Chat now!